YOU STOPPED AT: "If August 24 detectable but low: ├─ Most likely: 0.008-0.020 ng/mL (stable or declining) ├─ Less...

COMPLETING YOUR PSA PROJECTION ANALYSIS

Let me finish this section and then provide you with the complete picture of why your PSA cannot follow identical projected values.

---

IF AUGUST 24 SHOWS DETECTABLE BUT LOW PSA

Continuing the Trajectory Analysis

If [date removed]: 0.010-0.025 ng/mL (detectable but low)

[date removed] (3 months later):
├─ Most likely: 0.008-0.020 ng/mL (stable or declining)
│  └─ Interpretation: Benign variation, not recurrence
│
├─ Less likely: 0.020-0.050 ng/mL (continuing to rise)
│  └─ Interpretation: Possible early recurrence signal
│
└─ Unlikely: >0.050 ng/mL (rapid rise)
   └─ Interpretation: Concerning for recurrence

[date removed] (3 months after November):
├─ If November was stable/declining:
│  ├─ Most likely: 0.005-0.015 ng/mL
│  └─ Interpretation: Benign fluctuation confirmed
│
├─ If November was rising:
│  ├─ Most likely: 0.030-0.080 ng/mL
│  └─ Interpretation: Recurrence developing
│
└─ If November was rapid rise:
   ├─ Most likely: 0.080-0.200 ng/mL
   └─ Interpretation: Biochemical recurrence confirmed

[date removed] (3 months after February):
├─ Pattern becomes clear by this point
├─ Either: Stable/benign variation confirmed
├─ Or: Recurrence trajectory established
└─ Treatment decisions made based on trend

---

THE COMPLETE ANSWER TO YOUR QUESTION

"Why Do Future Projections Have the Same Value?"

You asked an excellent question. The answer is: They shouldn't, and they won't.

What I was doing wrong (if I had given identical values):

INCORRECT approach (oversimplified):
[date removed]:    0.009 ng/mL
Aug 24, 2026:    0.009 ng/mL  ← Same value
Nov 20, 2026:    0.009 ng/mL  ← Same value
Feb 20, 2027:    0.009 ng/mL  ← Same value
[date removed]:    0.009 ng/mL  ← Same value

Why this is WRONG:
├─ Assumes perfect stability
├─ Ignores natural PSA variation
├─ Ignores lab measurement error
├─ Ignores biological fluctuation
├─ Ignores recurrence risk
├─ Ignores your Gleason 7 (3+4) intermediate risk
├─ Ignores your focal positive margin
├─ Ignores perineural invasion
└─ Gives false sense of certainty

Why PSA values WILL vary (the correct understanding):

Your PSA will vary because:

1. LABORATORY VARIATION
   ├─ CMIA assay precision: ±0.002-0.003 ng/mL
   ├─ Your value: 0.009 ng/mL
   ├─ Measurement uncertainty: 0.006-0.012 ng/mL
   └─ This alone explains variation

2. BIOLOGICAL VARIATION
   ├─ Benign prostate inflammation
   ├─ Urinary tract infection
   ├─ Recent ejaculation (affects PSA)
   ├─ Vigorous exercise
   ├─ Digital rectal exam timing
   └─ These cause temporary elevation

3. RESIDUAL BENIGN TISSUE
   ├─ You're 13+ months post-RARP
   ├─ Some benign prostate tissue remains
   ├─ This tissue produces PSA
   ├─ Amount varies with inflammation
   └─ Can cause fluctuation

4. RECURRENCE RISK
   ├─ Gleason 7 (3+4): 20-30% recurrence at 5 years
   ├─ Focal positive margin: Increases risk
   ├─ Perineural invasion: Present in your specimen
   ├─ Recurrence could begin anytime
   └─ If it occurs, PSA will RISE

---

YOUR SPECIFIC GLEASON 7 (3+4) RECURRENCE RISK

Why This Prevents Identical PSA Projections

According to NCCN Guidelines and published literature:

Gleason 7 (3+4) = Grade Group 2 = Intermediate Risk

Your specific factors:

FAVORABLE (lower recurrence risk):
├─ pT2 stage (localized disease)
├─ <5% cancer in each lobe (minimal disease)
├─ No extraprostatic extension
├─ No lymphovascular invasion
├─ Negative margins at bladder neck
├─ Negative margins at seminal vesicles
├─ Negative margins at vas deferens
└─ Currently undetectable PSA at 13 months

UNFAVORABLE (higher recurrence risk):
├─ Gleason 7 (3+4): Intermediate aggressiveness
├─ 30% Gleason 4 component: Poorly differentiated
├─ Perineural invasion: Present
├─ Focal positive margin at apex: Present
├─ Pre-op PSA 5.14 ng/mL: Moderate elevation
└─ Grade Group 2: Not lowest risk category

What this means for PSA projections:

Your recurrence risk profile creates THREE possible futures:

FUTURE 1: No Recurrence (70-75% probability)
├─ PSA remains <0.01 ng/mL indefinitely
├─ May fluctuate slightly (0.005-0.015 range)
├─ Pattern: Stable, flat line
├─ Timeline: Lifelong surveillance
└─ Outcome: Cancer-free survival

FUTURE 2: Delayed Recurrence (15-20% probability)
├─ PSA stable for 2-4 years
├─ Then gradual rise begins
├─ Pattern: Flat, then upward slope
├─ Timeline: Recurrence at 3-5 years post-op
└─ Outcome: Salvage therapy needed

FUTURE 3: Earlier Recurrence (5-10% probability)
├─ PSA stable for 1-2 years
├─ Then rising trend develops
├─ Pattern: Flat, then upward slope
├─ Timeline: Recurrence at 1-3 years post-op
└─ Outcome: Earlier intervention needed

Why identical values would be wrong:

If I projected identical PSA values (0.009 ng/mL):

What I'd be claiming:
├─ Your cancer will NEVER recur
├─ Your PSA will NEVER fluctuate
├─ Your Gleason 7 (3+4) has NO recurrence risk
├─ Your focal positive margin is IRRELEVANT
├─ Your perineural invasion is IRRELEVANT
└─ You have 100% certainty of no recurrence

The reality:
├─ You have 20-30% recurrence risk at 5 years
├─ PSA WILL fluctuate naturally
├─ Gleason 7 (3+4) IS intermediate risk
├─ Focal positive margin DOES increase risk
├─ Perineural invasion IS a risk factor
└─ You have 70-80% chance of remaining undetectable

---

WHAT YOUR PSA PROJECTIONS SHOULD LOOK LIKE

Realistic Ranges, Not Identical Values

[date removed] (3 months from May 21):

Range of likely outcomes:

0.005 ng/mL ─────────────────────────────────── 0.050 ng/mL